NCT00309036已完成3 期
A Multicentre Randomised Placebo-controlled Double-blind Clinical Trial for Evaluation of Safety and Efficacy of Immunotherapy With an Aluminium Hydroxide-adsorbed Cocktail of Recombinant Derivatives of Major Allergens of Timothy Grass (Phleum Pratense).
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
The trial is performed to assess efficacy and safety of a recombinant grass Pollen allergen cocktail in allergic rhinoconjunctivitis
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Positive Skin Prick Test reaction to grass pollen
- •Positive RAST result to grass pollen
- •Positive Provocation Test result to grass pollen
排除标准
- •Serious chronic diseases
- •Other relevant perennial allergies
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic RhinoconjunctivitisGrass Pollen AllergyNCT00263601Allergopharma GmbH & Co. KG154
已完成
2 期
Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) AllergensType I-AllergyNCT00666341Allergopharma GmbH & Co. KG50
已完成
3 期
Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen MixtureGrass Pollen AllergyNCT00264459Allergopharma GmbH & Co. KG160
已完成
3 期
Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen AllergensPollen AllergyNCT00263627Allergopharma GmbH & Co. KG253
已完成
3 期
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic ConjunctivitisAllergic ConjunctivitisNCT00432757Vistakon Pharmaceuticals120